Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion

被引:22
作者
Riese, Juliane [1 ]
Loukopoulos, Vlassis [1 ]
Meier, Cornelia [1 ]
Timmermann, Melanie [1 ]
Gerding, Heinrich [1 ]
机构
[1] Augenzentrum Klin Pallas, Dept Retinol, CH-4600 Olten, Switzerland
关键词
Branch retinal vein occlusion; Macular edema; Intravitreal triamcinolone; Laser photocoagulation;
D O I
10.1007/s00417-008-0898-0
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
To determine the efficacy of combined intravitreal triamcinolone (TA) injection and laser photocoagulation in persistent macular edema after branch retinal vein occlusion (BRVO). Follow-up analysis of a case series of 24 patients with macular edema after BRVO (15 of 24 non-ischaemic, 9 of 24 ischaemic). Patients received an intravitreal injection of 4 mg TA followed by laser photocoagulation within the previously edematous area, applied in one or two sessions. Standardized clinical examinations included best corrected visual acuity testing, anterior and posterior segment biomicroscopy, intraocular pressure, and optical coherence tomography (OCT). Fluorescein angiography was performed before treatment and 3 and 6 months later. Median visual acuity improved significantly from 0.58 logMAR (95%-confidence interval (KI): 0.54 - 0.75, decimal 0.27) at baseline to 0.41 logMAR (KI: 0.37 - 0.64, decimal 0.39) at 1 month (p=0.001), 0.33 logMAR (KI: 0.32 - 0.62, decimal 0.47) at 3 months (p=0.002), and 0.41 logMAR (KI: 0.33 - 0.67, decimal 0.39) at 6 months (p=0.016). A gain of one or more logarithmic lines was evaluated in 16/24 eyes (67 %) and a gain of 3 lines or more in 8/24 eyes (33 %) at 6 months. Three eyes had lost more than 1 line during the follow-up period. Median change of visual acuity at 6 months was +2.0 lines (KI: 0.2 - 2.4). Median central foveal thickness (OCT-CFT) was 423 mu m (KI: 378 - 456, n=24) at baseline and decreased to 270 mu m (KI: 249 - 311, n=24) at 1 month (p < 0.0001), 265 mu m (KI: 254 - 344, n=24) at 3 months (p < 0.0001), and 266 mu m (KI: 259 - 365, n=18) at 6 months (p=0.001). Macular edema after BRVO can effectively be treated by a combination of intravitreal TA injection and subsequent laser photocoagulation. During a 6-month follow-up this combination treatment resulted in a significant reduction of central foveal thickness and improvement of visual acuity.
引用
收藏
页码:1671 / 1676
页数:6
相关论文
共 28 条
[11]   Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide [J].
Jonas, JB ;
Akkoyun, I ;
Kamppeter, B ;
Kreissig, I ;
Degenring, RF .
EYE, 2005, 19 (01) :65-71
[12]   Intravitreal triamcinolone acetonide: A change in a paradigm [J].
Jonas, Jost B. .
OPHTHALMIC RESEARCH, 2006, 38 (04) :218-245
[13]   Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion [J].
Kreutzer, T. C. ;
Alge, C. S. ;
Wolf, A. H. ;
Kook, D. ;
Burger, J. ;
Strauss, R. ;
Kunze, C. ;
Haritoglou, C. ;
Kampik, A. ;
Priglinger, S. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (03) :351-355
[14]   Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study [J].
Kriechbaum, K. ;
Michels, S. ;
Prager, F. ;
Georgopoulos, M. ;
Funk, M. ;
Geitzenauer, W. ;
Schmidt-Erfurth, U. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (04) :518-522
[15]   Intravitreal triamcinolone as primary treatment of cystoid macular edema secondary to branch retinal vein occlusion [J].
Lee, H ;
Shah, GK .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (05) :551-555
[16]   Sheathotomy to decompress branch retinal vein occlusion - A matched control study [J].
Mason, J ;
Feist, R ;
White, M ;
Swanner, J ;
McGwin, G ;
Emond, T .
OPHTHALMOLOGY, 2004, 111 (03) :540-545
[17]   Prevalence and associations of retinal vein occlusion in Australia - The blue mountains eye study [J].
Mitchell, P ;
Smith, W ;
Chang, A .
ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (10) :1243-1247
[18]  
Özkiris A, 2005, EUR J OPHTHALMOL, V15, P96
[19]   Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion [J].
Özkiris, AO ;
Evereklioglu, C ;
Erkilic, K ;
Dogan, H .
EYE, 2006, 20 (01) :13-17
[20]  
Parodi MB, 1999, GRAEF ARCH CLIN EXP, V237, P1024